Goodwin
Focusing on acquisitions in firmwide core industry sectors, including tech, life sciences and property, Goodwin continues to actively advise on behalf of a growing roster of private equity funds, which are appreciative of the firm's expertise advising on debt financing techniques throughout the capital structure. Simon Fulbrook and Hugh O’Sullivan co-head the team.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Goodwin has worked with us accessing large direct deals and small mid-market deals. The same team there can lead appropriate documentation for both - this is unique'
- 'Stand-out knowledge from Hugh O'Sullivan from legal issues on large to small-market terms. He also understands the inner workings of banks which helps management as much as it helps our firm.'
Key clients
- ECI Partners
- TowerBrook Capital Partners
- LDC
- Mayfair Equity Partners
- Partners Group
- Queens Park Equity
- TA Associates
- Bregal Milestone
- Tiancheng International Investment
- Wavecrest Partners
- G Square Private Equity
- H.I.G. Capital
- Inflexion
- Accel-KKR
- Thoma Bravo
Work highlights
- Advised TowerBrook Capital Partners on the financing to facilitate its acquisition of leading provider of premium finance for commercial and retail insurance products Premium Credit Limited from Cinven.
- Advised Biocon Biologics Ltd. (India’s largest biotech company) on the financing to facilitate its $3.33bn acquisition of the global biosimilars business of its partner Viatris Inc.
- Advised Accel-KKR on the debt financing for its acquisition of the PayProp group and the co-investment in the PayProp group by a consortium of its existing shareholders.
Practice head
The lawyer(s) leading their teams.
Simon Fulbrook, Hugh O’Sullivan